Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11744833 Pharmaceutical compositions and methods for treatment of insomnia

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Fengyuan Jia

Jianmin Wang

Date of Patent

September 5, 2023

Patent Application Number

17673136

Date Filed

February 16, 2022

Patent Citations

US Patent 10639316 Method of treating Parkinson's disease

US Patent 10946026 Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders

US Patent 10966989 Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders

US Patent 11318144 Compositions and methods for treating Alzheimer's disease and Parkinson's disease

US Patent 11351179 Pharmaceutical compositions and methods for treatment of psychiatric disorders

US Patent 11389458 Pharmaceutical compositions and methods for treating parkinson's and huntington's disease

US Patent 11690849 Method of treating dementia

US Patent 7220735 Benzimidazolone histamine H

...

Patent Citations Received

US Patent 11938139 Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders

0

Patent Primary Examiner

Leslie A. Royds Draper

Pharmaceutical compositions comprising azelastine or a pharmaceutically acceptable salt of azelastine and melatonin are disclosed. Methods of using the pharmaceutical compositions for treating patients suffering from insomnia are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11744833 Pharmaceutical compositions and methods for treatment of insomnia

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool